These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 16418196

  • 1. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
    Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S.
    Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
    Roccatello D, Baldovino S, Rossi D, Mansouri M, Naretto C, Gennaro M, Cavallo R, Alpa M, Costanzo P, Giachino O, Mazzucco G, Sena LM.
    Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
    [Abstract] [Full Text] [Related]

  • 3. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS, Wong CF.
    J Nephrol; 2007 Dec; 20(3):350-6. PubMed ID: 17557269
    [Abstract] [Full Text] [Related]

  • 4. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
    Korte MR, van Heerde MJ, de Man RA, Betjes MH.
    Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065
    [Abstract] [Full Text] [Related]

  • 5. Treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia--anti-viral therapy vs rituximab.
    Bruchfeld A, Saadoun D, Cacoub P.
    Rheumatology (Oxford); 2006 Jun; 45(6):783-4; author reply 784-5. PubMed ID: 16679341
    [No Abstract] [Full Text] [Related]

  • 6. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [Abstract] [Full Text] [Related]

  • 7. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
    Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S.
    Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
    Basse G, Ribes D, Kamar N, Mehrenberger M, Sallusto F, Esposito L, Guitard J, Lavayssière L, Oksman F, Durand D, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
    [Abstract] [Full Text] [Related]

  • 11. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
    Medeot M, Zaja F, Vianelli N, Battista M, Baccarani M, Patriarca F, Soldano F, Isola M, De Luca S, Fanin R.
    Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
    [Abstract] [Full Text] [Related]

  • 12. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
    Ghinoi A, Mascia MT, Puccini R, Ferri C.
    G Ital Nefrol; 2004 Sep; 21(3):225-37. PubMed ID: 15285001
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of low-dose rituximab for mixed cryoglobulinemia.
    Visentini M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M.
    Clin Immunol; 2007 Oct; 125(1):30-3. PubMed ID: 17692572
    [Abstract] [Full Text] [Related]

  • 14. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK, Wittekind C, Niederwieser D.
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S, Borrelli S, Catapano F, Mascia S, D'Angio' P, Calabria M, Grimaldi M, Salvio A, Minutolo R, De Nicola L, Conte G.
    G Ital Nefrol; 2009 Aug; 26(3):318-27. PubMed ID: 19554529
    [Abstract] [Full Text] [Related]

  • 16. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H, Ribes D, Modesto A, Kamar N, Durand D, Rostaing L.
    Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
    [Abstract] [Full Text] [Related]

  • 17. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K, Prins C, Saurat JH, French LE.
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.
    Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P.
    Am J Kidney Dis; 2013 Apr 15; 61(4):623-37. PubMed ID: 23102733
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
    Lo KY, Chen CY, Lee CS.
    Ren Fail; 2009 Apr 15; 31(2):149-52. PubMed ID: 19212913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.